Exact Mass: 378.0828134

Exact Mass Matches: 378.0828134

Found 64 metabolites which its exact mass value is equals to given mass value 378.0828134, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

7-Methylguanosine 5'-phosphate

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-6-hydroxy-2-imino-7-methyl-3,9-dihydro-2H-purin-7-ium

C11H17N5O8P+ (378.0814712)


7-methylguanosine 5-phosphate is part of the RNA degradation pathway. It is a substrate for: m7GpppX diphosphatase, and m7GpppX diphosphatase.

   

Carbenicillin

(2S,5R,6R)-6-{[carboxy(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C17H18N2O6S (378.0885528)


Carbenicillin is only found in individuals that have used or taken this drug. It is a broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function. [PubChem]Free carbenicillin is the predominant pharmacologically active fraction of the salt. Carbenicillin exerts its antibacterial activity by interference with final cell wall synthesis of susceptible bacteria. Penicillins acylate the penicillin-sensitive transpeptidase C-terminal domain by opening the lactam ring. This inactivation of the enzyme prevents the formation of a cross-link of two linear peptidoglycan strands, inhibiting the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that carbenicillin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Enterolactone 3'-sulfate

(3-{[(3S,4S)-4-[(3-hydroxyphenyl)methyl]-2-oxooxolan-3-yl]methyl}phenyl)oxidanesulphonic acid

C18H18O7S (378.07731980000005)


   

Enterolactone 3'-sulfate

(3-{[(3S,4S)-4-[(3-hydroxyphenyl)methyl]-5-oxooxolan-3-yl]methyl}phenyl)oxidanesulphonic acid

C18H18O7S (378.07731980000005)


   

2,2-Dichloro-12-(4-chlorophenyl)dodecanoic acid

2,2-Dichloro-12-(p-chlorophenyl)-dodecanoic acid

C18H25Cl3O2 (378.092004)


   

Taiwanin E methyl ether

Taiwanin E methyl ether

C21H14O7 (378.0739494)


   

Phellifuropyranone A

Phellifuropyranone A

C21H14O7 (378.0739494)


   
   

Anastatin A

(2S) -2,3-Dihydro-5,7,8-trihydroxy-2- (4-hydroxyphenyl) -4H-Benzofuro [ 3,2-g ] -1-benzopyran-4-one

C21H14O7 (378.0739494)


   

anastatin B

(2S)-2,3-Dihydro-5,9,10-trihydroxy-2-(4-hydroxyphenyl)-4H-benzofuro[2,3-h]-1-benzopyran-4-one

C21H14O7 (378.0739494)


   

Jusmicranthin methyl ether

Jusmicranthin methyl ether

C21H14O7 (378.0739494)


   
   

Justicidin G

Justicidin G

C21H14O7 (378.0739494)


Annotation level-1

   
   
   
   

jusmicranthin methyl ester|jusmicranthin methyl ether

jusmicranthin methyl ester|jusmicranthin methyl ether

C21H14O7 (378.0739494)


   
   

(ent-6alpha,8alpha,10beta,12betaH)-17-Chloro-15,16-epoxy-8-hydroxy-19-nor-4,13(16),14-clerodatriene-18,6:20,12-diolide

(ent-6alpha,8alpha,10beta,12betaH)-17-Chloro-15,16-epoxy-8-hydroxy-19-nor-4,13(16),14-clerodatriene-18,6:20,12-diolide

C19H19ClO6 (378.0870104)


   

14-hydroxy-8beta-methacryloyloxy-3-chlorodehydroleucodin

14-hydroxy-8beta-methacryloyloxy-3-chlorodehydroleucodin

C19H19ClO6 (378.0870104)


   
   
   
   
   

5-(3,4-Dimethoxyphenyl)naphtho[2,3-d]-1,3-dioxole-6,7-dicarboxylic anhydride

5-(3,4-Dimethoxyphenyl)naphtho[2,3-d]-1,3-dioxole-6,7-dicarboxylic anhydride

C21H14O7 (378.0739494)


   

Asp-His-OH

(S)-2-(3-(carboxymethoxy)-4-nitrobenzamido)-4-(1H-imidazol-4-yl)butanoic acid

C15H14N4O8 (378.0811604)


   

7-methylguanosine 5'-phosphate

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-6-hydroxy-2-imino-7-methyl-3,9-dihydro-2H-purin-7-ium

C11H17N5O8P (378.0814712)


   
   

2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-di benzoate

2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-di benzoate

C19H16F2O6 (378.09148999999996)


   

N-(2,5-difluorophenyl)-5-[4-(trifluoromethyl)phenyl]pyridine-3-carboxamide

N-(2,5-difluorophenyl)-5-[4-(trifluoromethyl)phenyl]pyridine-3-carboxamide

C19H11F5N2O (378.0791496)


   

N-(2,5-difluorophenyl)-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide

N-(2,5-difluorophenyl)-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide

C19H11F5N2O (378.0791496)


   
   

2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate

2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate

C19H16F2O6 (378.09148999999996)


   

3,3-CARBONYLBIS(7-METHOXYCOUMARIN)

3,3-CARBONYLBIS(7-METHOXYCOUMARIN)

C21H14O7 (378.0739494)


   

Vortioxetine hydrobromide

Vortioxetine (Lu AA21004) HBr

C18H23BrN2S (378.0765218)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Vortioxetine hydrobromide is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.

   
   

2-Deoxy-2,2-difuoro-D-ribofuranose-3,5-dibenzoate

2-Deoxy-2,2-difuoro-D-ribofuranose-3,5-dibenzoate

C19H16F2O6 (378.09148999999996)


   

2-DEOXY-2,2-DIFLUORO-D-RIBOFURANOSE-3,5-DIBENZOATES

2-DEOXY-2,2-DIFLUORO-D-RIBOFURANOSE-3,5-DIBENZOATES

C19H16F2O6 (378.09148999999996)


   

4,6-dimethylpyrimidin-2-ol--1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulphonic acid (1:1)

4,6-dimethylpyrimidin-2-ol--1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulphonic acid (1:1)

C17H18N2O6S (378.0885528)


   

Laquinimod sodium

Laquinimod sodium

C19H16ClN2NaO3 (378.0747096)


C308 - Immunotherapeutic Agent

   

8-(Butan-2-ylthio)-7-[(4-chlorophenyl)methyl]-3-methylpurine-2,6-dione

8-(Butan-2-ylthio)-7-[(4-chlorophenyl)methyl]-3-methylpurine-2,6-dione

C17H19ClN4O2S (378.0917184)


   
   

N-({3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-YL}methyl)-D-glutamic acid

N-({3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-YL}methyl)-D-glutamic acid

C13H19N2O9P (378.0828134)


   
   

[4-[(2,4-Dichlorophenoxy)methyl]phenyl]-(4-methyl-1-piperazinyl)methanone

[4-[(2,4-Dichlorophenoxy)methyl]phenyl]-(4-methyl-1-piperazinyl)methanone

C19H20Cl2N2O2 (378.090176)


   
   

N-[[2-methyl-5-(2-oxazolo[4,5-b]pyridinyl)anilino]-sulfanylidenemethyl]-2-furancarboxamide

N-[[2-methyl-5-(2-oxazolo[4,5-b]pyridinyl)anilino]-sulfanylidenemethyl]-2-furancarboxamide

C19H14N4O3S (378.0786574)


   

N-(3,5-dimethoxyphenyl)-6-methyl-3-oxo-4H-1,4-benzoxazine-7-sulfonamide

N-(3,5-dimethoxyphenyl)-6-methyl-3-oxo-4H-1,4-benzoxazine-7-sulfonamide

C17H18N2O6S (378.0885528)


   

N-[1,1,1,3,3,3-hexafluoro-2-(2-pyridinylmethylamino)propan-2-yl]-3-pyridinecarboxamide

N-[1,1,1,3,3,3-hexafluoro-2-(2-pyridinylmethylamino)propan-2-yl]-3-pyridinecarboxamide

C15H12F6N4O (378.09152539999997)


   

4-[(E)-[4-(furan-2-yl)-2-pyridin-3-ylimino-1,3-thiazol-3-yl]iminomethyl]benzene-1,3-diol

4-[(E)-[4-(furan-2-yl)-2-pyridin-3-ylimino-1,3-thiazol-3-yl]iminomethyl]benzene-1,3-diol

C19H14N4O3S (378.0786574)


   

4-O-(alpha-L-rhamnopyranosyl)-5-O-phosphono-D-ribitol

4-O-(alpha-L-rhamnopyranosyl)-5-O-phosphono-D-ribitol

C11H23O12P (378.0927088)


   

[3-[(E)-(1,3-benzodioxole-5-carbonylhydrazinylidene)methyl]phenyl] furan-2-carboxylate

[3-[(E)-(1,3-benzodioxole-5-carbonylhydrazinylidene)methyl]phenyl] furan-2-carboxylate

C20H14N2O6 (378.0851824)


   

Carbenicillin

Carbenicillin

C17H18N2O6S (378.0885528)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic A penicillin antibiotic having a 6beta-2-carboxy-2-phenylacetamido side-chain.

   

7-Methylguanosine 5-phosphate

7-Methylguanosine 5-phosphate

C11H17N5O8P+ (378.0814712)


   

alpha-L-Rhap-(1->4)-D-ribitol-5-phosphate

alpha-L-Rhap-(1->4)-D-ribitol-5-phosphate

C11H23O12P (378.0927088)


A disaccharide derivative consisting of D-ribitol-5-phosphate having an alpha-L-rhamnosyl residue attached at the 4-position.

   

4',6,7,8-tetrahydroxy-1-methyl-1'h-spiro[naphtho[2,3-c]furan-4,2'-quinazolin]-9-one

4',6,7,8-tetrahydroxy-1-methyl-1'h-spiro[naphtho[2,3-c]furan-4,2'-quinazolin]-9-one

C20H14N2O6 (378.0851824)


   

(3s,4'r,5s,6's,8'r)-6'-(chloromethyl)-5-(furan-3-yl)-6'-hydroxy-3'-oxaspiro[oxolane-3,7'-tricyclo[6.3.1.0⁴,¹²]dodecan]-1'(12')-ene-2,2'-dione

(3s,4'r,5s,6's,8'r)-6'-(chloromethyl)-5-(furan-3-yl)-6'-hydroxy-3'-oxaspiro[oxolane-3,7'-tricyclo[6.3.1.0⁴,¹²]dodecan]-1'(12')-ene-2,2'-dione

C19H19ClO6 (378.0870104)


   

10-(7-methoxy-2h-1,3-benzodioxol-5-yl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one

10-(7-methoxy-2h-1,3-benzodioxol-5-yl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one

C21H14O7 (378.0739494)


   

(3ar,4r,9ar,9br)-8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylprop-2-enoate

(3ar,4r,9ar,9br)-8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylprop-2-enoate

C19H19ClO6 (378.0870104)


   

8,13,14-trihydroxy-4-(4-hydroxyphenyl)-3,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),8,11(16),12,14-hexaen-6-one

8,13,14-trihydroxy-4-(4-hydroxyphenyl)-3,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),8,11(16),12,14-hexaen-6-one

C21H14O7 (378.0739494)